FDA cleared the Evident Vascular™ Guidance System from Evident Vascular, Inc. on Oct 28, 2026 under K261648, a traditional 510(k). The device falls under product code IYO, System, Imaging, Pulsed Echo, Ultrasonic, regulated at 21 CFR 892.1560 as a Class 2 device. The review panel was Radiology.

FDA logged the submission as received on May 18, 2026. The decision came 163 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Evident Vascular, Inc. in the last 12 months of the tracker.